NFKB1 and chronic obstructive pulmonary disease: It has also been reported to reduce the expression levels of IL-1b and TNF-α in the lung tissue of a COPD mouse model and suppress airway inflammation and mucus production by inhibiting NF-κB activity in an OVA-induced asthmatic murine model [40,41,42].